Evidence against RAB40AL being the locus for Martin-Probst X-linked deafness-intellectual disability syndrome

Monika Ołdak1, Aneta Ścieżyńska, Wojciech Młynarski

  • 1Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland; Institute of Physiology and Pathology of Hearing, Warsaw, Poland.

Human Mutation
|July 22, 2014
PubMed

Insights

The RAB40AL gene is not the cause of Martin-Probst syndrome (MPS). The common p.D59G variant, previously linked to MPS, is prevalent in healthy individuals, questioning its disease-causing role.

Area of Science:

  • Genetics
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Martin-Probst syndrome (MPS) is an X-linked disorder characterized by deafness and intellectual disability.
  • The RAB40AL gene was previously suggested as the locus for MPS based on limited family segregation and in vitro studies of a specific missense variant (p.D59G).

Purpose of the Study:

  • To investigate the role of the RAB40AL gene, specifically the p.D59G variant, in the etiology of Martin-Probst syndrome.
  • To assess the prevalence of the p.D59G variant in a general population to determine if it represents a disease-causing mutation or a common polymorphism.

Main Methods:

  • Whole-exome sequencing was performed on two patients with suspected MPS.
  • The p.D59G variant was screened in 810 DNA samples from a general Polish population using allele-specific PCR and direct DNA sequencing for verification.

Main Results:

  • The p.D59G variant was identified in two patients, but MPS was excluded in both cases.
  • Screening revealed the p.D59G variant in 2.47% of the general Polish population (8/405 males, 12/405 females), indicating high prevalence.
  • The observed frequency of the p.D59G variant is consistent with a common genetic variation in asymptomatic individuals.

Conclusions:

  • The findings challenge the role of RAB40AL mutations, particularly the p.D59G variant, as the cause of Martin-Probst syndrome.
  • The high prevalence of the p.D59G variant in the general population suggests it is not pathogenic for MPS.
  • This study has significant diagnostic implications given the increasing use of next-generation sequencing in clinical practice.